Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
-39.06%
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthAccelerating
Average
-42.76%
Historical baseline
PeriodValue
2025-39.06%
2024-41.33%
2023-36.99%
2022-28.42%
2021-114.33%
2020-39.15%
20190.00%